Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"

• Status: Completed
• Trial end date: 2013-05-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this survey is to investigate the safety and efficacy of long-term use of candesartan cilexetil/amlodipine besilate combination tablets (Unisia Combination Tablets) low dose (LD), high dose (HD) in participants with hypertension in the normal clinical setting.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Takeda
• Treatments: Amlodipine; Candesartan; Candesartan cilexetil

Criteria

Inclusion Criteria:

1. Participants with hypertension

Exclusion Criteria:

1. Participants in whom Candesartan cilexetil/Amlodipine besilate is contraindicated [Contraindications]

2. Participants with a history of hypersensitivity to the ingredients of Candesartan cilexetil/Amlodipine besilate or any other dihydropyridine formulations

3. Women who are pregnant or of child-bearing potential